Natalie Danziger

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Epidermal Growth Factor Receptor

Brain Metastases

Top Venues

JCO precision oncology

NPJ precision oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie Danziger, Dean C Pavlick, Anil Korkut, Jeffery S Ross, Milind M Javle
Comprehensive Immunogenomic Profiling of IDH1- / 2 -Altered Cholangiocarcinoma. JCO precision oncology 8 (2024)
Douglas I Lin, Julia C F Quintanilha, Natalie Danziger, Lixin Lang, Diane Levitan, Cynthia Hayne, Matthew C Hiemenz, David L Smith, Lee A Albacker, Jeffrey Leibowitz, Douglas A Mata, Brennan Decker, Sotirios Lakis, Nimesh R Patel, Ryon P Graf, Julia A Elvin, Jeffrey S Ross, Varun Pattani, Richard S P Huang, Amy K Wehn
Pan-tumor validation of a NGS fraction-based MSI analysis as a predictor of response to Pembrolizumab. NPJ precision oncology 8 (1) (2024)
Debra L Richardson, Julia Coelho França Quintanilha, Natalie Danziger, Gerald Li, Ethan S Sokol, Alexa B Schrock, Ericka M Ebot, Neeru Bhardwaj, Tanesha Norris, Anosheh Afghahi, Anthony Frachioni, Christina R Washington, Lauren Dockery, Julia A Elvin, Ryon P Graf, Kathleen M Moore
Effectiveness of PARP inhibitor maintenance therapy in ovarian cancer by BRCA1/2 and a scar-based HRD signature in real-world practice. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie Danziger, Dean C Pavlick, Anil Korkut, Jeffery S Ross, Milind M Javle
Comprehensive Immunogenomic Profiling of IDH1- / 2 -Altered Cholangiocarcinoma. JCO precision oncology 8 (2024)
Shalini Makawita, Sunyoung Lee, Elisabeth Kong, Lawrence N Kwong, Zeyad Abouelfetouh, Anaemy Danner De Armas, Lianchun Xiao, Karthikeyan Murugesan, Natalie Danziger, Dean C Pavlick, Anil Korkut, Jeffery S Ross, Milind M Javle
Comprehensive Immunogenomic Profiling of IDH1- / 2 -Altered Cholangiocarcinoma. JCO precision oncology 8 (2024)
Vamsi Parimi, Khaled Tolba, Natalie Danziger, Zheng Kuang, Daokun Sun, Douglas I Lin, Matthew C Hiemenz, Alexa B Schrock, Jeffrey S Ross, Geoffrey R Oxnard, Richard S P Huang
Genomic landscape of 891 RET fusions detected across diverse solid tumor types. NPJ precision oncology 7 (1) (2023)
Vamsi Parimi, Khaled Tolba, Natalie Danziger, Zheng Kuang, Daokun Sun, Douglas I Lin, Matthew C Hiemenz, Alexa B Schrock, Jeffrey S Ross, Geoffrey R Oxnard, Richard S P Huang
Genomic landscape of 891 RET fusions detected across diverse solid tumor types. NPJ precision oncology 7 (1) (2023)
Vamsi Parimi, Khaled Tolba, Natalie Danziger, Zheng Kuang, Daokun Sun, Douglas I Lin, Matthew C Hiemenz, Alexa B Schrock, Jeffrey S Ross, Geoffrey R Oxnard, Richard S P Huang
Genomic landscape of 891 RET fusions detected across diverse solid tumor types. NPJ precision oncology 7 (1) (2023)
Ibiayi Dagogo-Jack, Russell W Madison, Jochen K Lennerz, Kuei-Ting Chen, Julia F Hopkins, Alexa B Schrock, Lauren L Ritterhouse, Ashley Lester, Keith A Wharton, Mari A Mino-Kenudson, Natalie Danziger, Yin P Hung, Douglas A Mata, Jeffery S Ross
Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape. JCO precision oncology 6 (2022)
Smruthy S Sivakumar, Dexter X Jin, Hanna Tukachinsky, Karthikeyan Murugesan, Kimberly McGregor, Natalie Danziger, Dean Pavlick, Ole Gjoerup, Jeffrey S Ross, Robert Harmon, Jon Chung, Brennan Decker, Lucas Dennis, Garrett M Frampton, Luciana Molinero, Steffi Oesterreich, Jeffrey M Venstrom, Geoffrey R Oxnard, Priti S Hegde, Ethan S Sokol
Tissue and liquid biopsy profiling reveal convergent tumor evolution and therapy evasion in breast cancer. Nature communications 13 (1) (2022)
Sarah L Sammons, Kira Raskina, Natalie Danziger, Laura Alder, Alexa B Schrock, Jeffrey M Venstrom, Keith L Knutson, E Aubrey Thompson, Kim McGregor, Ethan S Sokol, Saranya Chumsri
APOBEC Mutational Signatures in Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancers Are Associated With Poor Outcomes on CDK4/6 Inhibitors and Endocrine Therapy. JCO precision oncology 6 (2022)
Gennady Bratslavsky, Ethan S Sokol, Michael Daneshvar, Andrea Necchi, Oleg Shapiro, Joseph Jacob, Nick Liu, Tom S Sanford, Ruben Pinkhasov, Hanan Goldberg, Jonathan K Killian, Shakti Ramkissoon, Eric A Severson, Richard S P Huang, Natalie Danziger, Mehdi Mollapour, Jeffrey S Ross, Karel Pacak
Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling Study. Cancers 13 (13) (2021)